Stryker's 2020 net sales dropped 3.6 percent, largely due to the COVID-19 pandemic.
Spinal Tech
Medtronic released its "2020 Global Inclusion, Diversity and Equity Report" which outlines the company's actions for developing and retaining diverse talent.
During Johnson & Johnson's fourth-quarter earnings call, CEO Alex Gorsky projected elective surgical volumes to be most affected in the first quarter, but hopes improved vaccine distribution will lead to more "normalized levels" toward the end of the year, according…
The FDA has granted clearance for the Trident SI joint screw system, developed by surgeons from Burnsville, Minn.-based Inspired Spine, according to a Jan. 26 news release.
Chicago-based Granite Creek Capital Partners has invested in implant manufacturer Life Spine.
Advertisement
Here's how Medtronic, Stryker and Johnson & Johnson's shares have fluctuated over the last five days.
Johnson & Johnson's orthopedics sales dropped 12.2 percent year over year in 2020 to $7.7 billion. Sales declined 10.2 percent in the U.S. and 15.2 percent worldwide.
The orthopedic implant market has growth in store and is expected to hit $8.97 billion by 2025, according to a January report from Fior Markets.
From one acquisition in the foot and ankle space to two new product launches, here are the latest device company notes:
Orthopedic device company Sacrix launched the third iteration of SacroFuse, a threaded compression device designed for immediate stabilization of the sacroiliac joint.